NCT02129803View on ClinicalTrials.gov

Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis

NACompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

May 29, 2019

Study Completion Date

May 29, 2019

Conditions
Cystic Fibrosis
Interventions
DEVICE

High-Flow, 20 LPM (via Optiflow cannula)

Nasal high flow humidification (20LPM) therapy will be administered using Optiflow with Airvo 2.

DEVICE

Low FLow, 5 LPM (via Optiflow cannula)

standard humidified wall medical air.

Trial Locations (1)

23298

Children's Hospital of Richmond at VCU, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT02129803 - Evaluating High Flow Humidification Therapy in Patients With Cystic Fibrosis | Biotech Hunter | Biotech Hunter